Perindopril Erbumine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2021 publications
Perindopril: A comprehensive profile.
Journal: Profiles of drug substances, excipients, and related methodology
Published: February 19, 2026
Dual calcium-ACE inhibition reverses non alcoholic fatty pancreas progression: Mechanistic convergence on miR-762/GPX4 driven NLRP3 inflammasome activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 27, 2025
Polypharmacy and Drug-Drug Interaction Architecture in Hospitalized Cardiovascular Patients: Insights from Real-World Analysis.
Journal: Biomedicines
Published: December 22, 2025
Long-term risk of dementia with angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive patients: A 15-year follow-up using the 45 and Up Study.
Journal: GeroScience
Published: December 03, 2025
Comparative efficacy of pharmacological agents on abdominal aortic aneurysm growth rate: a systematic review and network meta-analysis.
Journal: Frontiers in pharmacology
Published: October 18, 2025
Retraction Note.
Journal: European review for medical and pharmacological sciences
Published: October 08, 2025
Role of Perindopril in Mitigating Doxorubicin's Vascular Toxicity in a Rat Model.
Journal: Cardiovascular toxicology
Published: August 02, 2025
Quadruple vs triple therapy for resistant hypertension: the QUADRO trial.
Journal: European heart journal
Published: July 03, 2025
Cardioprotective effect of Yiqi Huoxue decoction on post-myocardial infarction injury mediated by Ca2+ flux through MAMs.
Journal: Frontiers in cardiovascular medicine
Published: April 07, 2025
Last Updated: 04/28/2026